Annals of Oncology · 2020 · 33 citations · 0 references
MedicineOncologyPharmacologyCancer PharmacologyChemotherapyNeoplasiaMalignant NeoplasmsOncogene MutationsPharmacodynamics Of Anticancer AgentsPharmacodynamics Of Anticancer DrugsTherapeutic ResistanceDurvalumab Consolidation TherapyDurvalumab TherapyTumor Mutation Burden AssessmentTumor Mutation Burden BiomarkersTumor Mutational BurdenTumor Mutational Burden AssessmentTumor Mutational Burden Interpretation